Zhejiang Hisun Biomaterials Stock Price To Book
| 688203 Stock | 10.83 0.14 1.31% |
Zhejiang HISUN Biomaterials fundamentals help investors to digest information that contributes to Zhejiang HISUN's financial success or failures. It also enables traders to predict the movement of Zhejiang Stock. The fundamental analysis module provides a way to measure Zhejiang HISUN's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Zhejiang HISUN stock.
Zhejiang | Price To Book |
Zhejiang HISUN Biomaterials Company Price To Book Analysis
Zhejiang HISUN's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Zhejiang HISUN Price To Book | 1.44 X |
Most of Zhejiang HISUN's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zhejiang HISUN Biomaterials is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Zhejiang HISUN Biomaterials has a Price To Book of 1.443 times. This is 88.15% lower than that of the Chemicals sector and 56.54% lower than that of the Materials industry. The price to book for all China stocks is 84.83% higher than that of the company.
Zhejiang Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zhejiang HISUN's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zhejiang HISUN could also be used in its relative valuation, which is a method of valuing Zhejiang HISUN by comparing valuation metrics of similar companies.Zhejiang HISUN is currently under evaluation in price to book category among its peers.
Zhejiang Fundamentals
| Return On Equity | 0.0267 | |||
| Return On Asset | 0.012 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 1.83 B | |||
| Shares Outstanding | 202.68 M | |||
| Shares Owned By Insiders | 70.21 % | |||
| Shares Owned By Institutions | 1.15 % | |||
| Price To Book | 1.44 X | |||
| Price To Sales | 2.51 X | |||
| Revenue | 753.32 M | |||
| Gross Profit | 80.89 M | |||
| EBITDA | 100.72 M | |||
| Net Income | 43.55 M | |||
| Total Debt | 179.55 M | |||
| Book Value Per Share | 7.39 X | |||
| Cash Flow From Operations | 163.03 M | |||
| Earnings Per Share | 0.20 X | |||
| Number Of Employees | 383 | |||
| Beta | 0.66 | |||
| Market Capitalization | 2.17 B | |||
| Total Asset | 2.05 B | |||
| Retained Earnings | 65.57 M | |||
| Working Capital | 627.83 M | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 2.05 B | |||
| Last Dividend Paid | 0.08 |
About Zhejiang HISUN Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zhejiang HISUN Biomaterials's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhejiang HISUN using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhejiang HISUN Biomaterials based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Zhejiang Stock
Zhejiang HISUN financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang HISUN security.